Characterization of the scope and magnitude of biotin interference in susceptible Roche Elecsys competitive and sandwich immunoassays

Annals of Clinical Biochemistry

Volumn 55, Issue 2, 2018, Pages 205-215

  Trambas, Christina ^a   Lu, Zhong ^a,b   Yen, Tina ^a,c   Sikaris, Ken ^a  

^a MELBOURNE PATHOLOGY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Biotin; Elecsys; immunoassay; interference; Roche

Indexed keywords

BIOTIN; THYROID ANTIBODY; THYROTROPIN; TROPONIN T;

ANALYTICAL ERROR; ARTICLE; COMPETITIVE IMMUNOASSAY; CONTROLLED STUDY; IMMUNOASSAY; MAXIMUM CONCENTRATION; MINIMUM CONCENTRATION; PRIORITY JOURNAL; SANDWICH IMMUNOASSAY; ARTIFACT; BLOOD; CHEMISTRY; HUMAN; PROCEDURES;

ARTIFACTS; BIOTIN; HUMANS; IMMUNOASSAY;

EID: 85042778962     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563217701777     Document Type: Article

References (39)

1. Dundas CM, Demonte D, Park S. Streptavidin-biotin technology: improvements and innovations in chemical and biological applications. Appl Microbiol Biotechnol 2013; 97: 9343–9353.
2. Diamandis EP, Christopoulos TK. The biotin-(strept)avidin system: principles and applications in biotechnology. Clin Chem 1991; 37: 625–636.
3. Henry JG, Sobki S, Arafat N. Interference by biotin therapy on measurement of TSH and FT4 by enzyme immunoassay on Boehringer Mannheim ES700 analyser. Ann Clin Biochem 1996; 33: 162–163.
4. Baumgartner MR. Vitamin responsive disorders: cobalamin, folate, biotin, vitamins B1 and E. Handbook Clin Neurol 2013; 113: 1799–1810.
5. Kwok JS, Chan IH, Chan MH. Biotin interference on TSH and free thyroid hormone measurement. Pathology 2012; 44: 278–280.
6. Wijeratne NG, Doery JC, Lu ZX. Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study. Pathology 2012; 44: 674–675.
7. Kummer S, Hermsen D, Distelmaier F. Biotin treatment mimicking Graves' disease. N Engl J Med 2016; 375: 704–706.
8. Bülow Pedersen I, Laurberg P. Biochemical hyperthyroidism in a newborn baby caused by assay interaction from biotin intake. Eur Thyroid J 2016; 5: 212–215.
9. Sedel F, Papeix C, Bellanger A, High doses of biotin in chronic progressive multiple sclerosis: a pilot study. Mult Scler Relat Disord 2015; 4: 159–169.
10. Tourbah A, Lebrun-Frenay C, Edan G, MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomised, double-blind, placebo-controlled study. Mult Scler 2016; 22: 1719–1731.
11. Thompson AJ, Uitdehaag B, Taylor B, et al.; on behalf of the MSIF. Atlas of MS 2013: mapping MS around the world. Multiple Sclerosis International Federation, www.msif.org/wp-content/uploads/2014/09/Atlas-of-MS.pdf (accessed 1 November 2016)
12. Seaborg E. Thyroid month: beware of biotin. Endocrine Society Endocrine News, January 2016, http://endocrinenews.endocrine.org/january-2016-thyroid-month-beware-of-biotin/ (accessed 15 March 2016)
13. Barbesino G. Misdiagnosis of Graves' disease with apparent severe hyperthyroidism in a patient taking biotin megadoses. Thyroid 2016; 26: 860–863.
14. Trambas CM, Sikaris KA, Lu ZX. A caution regarding high-dose biotin therapy: misdiagnosis of hyperthyroidism in euthyroid patients. Med J Aust 2016; 205: 192–192.
15. Elston MS, Seghal S, Du Toit S, Factitious Graves’ disease due to biotin immunoassay interference – a case and review of the literature. J Clin Endocrinol Metab 2016; 101: 3251–3255.
16. Piketty ML, Polak M, Flechtner I, et al. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences” Clin Chem Lab Med. Epub ahead of print 1 November 2016. doi: 10.1515/cclm-2016-0606
17. Batista MC, Ferreira CE, Fauhaber AC, et al. Biotin interference in immunoassays mimicking subclinical Graves' disease and hyperestrogenism: a case series. Clin Chem Lab Med. Epub ahead of print 8 October 2016
18. Minkovsky A, Lee MN, Dowlatshahi M, High-dose biotin treatment for secondary progressive multiple sclerosis may interfere with thyroid assays. AACE Clin Case Rep 2016; 2: e370–e373.
19. Trambas CM, Sikaris KA, Lu ZX. More on biotin treatment mimicking Graves' disease. N Engl J Med 2016; 375: 1698–1698.
20. Meany DL, Jan de Beur SM, Bill MJ, A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations. Clin Chem 2009; 55: 1737–1739.
21. Roche Diagnostics GmbH. Roche Elecsys method sheets. Manheim: Roche Diagnostics GmbH, 2016
22. Peyro Saint Paul L, Debruyne D, Bernard D, Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis. Expert Opin Drug Metab Toxicol 2016; 12: 327–344.
23. Zempleni J, Mock JM. Bioavailability of biotin given orally to humans in pharmacologic doses. Am J Clin Nutr 1999; 69: 504–508.
24. Zempleni J, Mock DM. Modern analytical methodologies on fat and water-soluble vitamins, New York, NY: Wiley, 2000, pp. 389–409.
25. Mock DM, Mock N. Serum concentrations of bisnorbiotin and biotin sulfoxide increase during both acute and chronic biotin supplementation. J Lab Clin Med 1997; 129: 384–388.
26. Bitsch R, Salz I, Hötzel D. Studies on bioavailability of oral biotin doses for humans. Int J Vitam Nutr Res 1989; 59: 65–71.
27. Ross DS, Burch HB, Cooper DS, 2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 2016; 26: 1343–1421.
28. Ortho Clinical Diagnostics. Vitros Immunodiagnostic product insert sheets. Raritan: Ortho Clinical Diagnostics, 2016
29. Beckman Coulter Inc. Access immunoassay product sheets. Brea, CA: Beckman Coulter Inc, 2016
30. Immunodiagnostic Systems GmbH. iSYS immunoassay product sheets. Frankfurt am Main: Immunodiagnostic Systems GmbH, 2016
31. Siemens Healthineers. ADVIA Centaur immunoassay product sheets. Erlangen: Siemens Healthineers, 2016
32. Siemens Healthineers. Personal communication from Siemens. Siemens Healthineers, 2016
33. TnI-Ultra Biotin Interference. Urgent field safety notice CC 16-12.A.OUS. Siemens. May, 2016
34. Siemens Healthineers. Dimension Vista LOCI immunoassay product sheets. Erlangen: Siemens Healthineers, 2016
35. Abbott Diagnostics. Architect immunoassay product sheets. Abbott Park: Abbott Diagnostics, 2016
36. DiaSorin. Liaison XL immunoassay product sheets. Saluggia: DiaSorin, 2016
37. Zempleni J, Kuroishi T. Biotin. Adv Nutr 2012; 3: 213–214.
38. Harthé C, Claustrat B. A sensitive and practical competitive radioassay for plasma biotin. Ann Clin Biochem 2003; 40: 259–263.
39. Zempleni J, Wijeratne SS, Hassan YI. Biotin. Biofactors 2009; 35: 36–46.